10 瓶装库存 4立省 25%Retatrutide 10 mg
GLP-1 / GIP / 胰高血糖素三激动剂研究用肽
Retatrutide tri-agonist research peptide, Australian-shipped. Lab-verified ≥99% purity.
仅供研究使用。 本化合物严格用于体外研究及实验室用途，不得用于人体食用或治疗用途。购买即确认您为合格研究者，并同意我们的 完整免责声明。
仅剩 4 盒
三受体激动剂研究用肽，文献关注其在代谢研究中对 GLP-1、GIP 与胰高血糖素信号通路的联合作用。
Retatrutide is a synthetic tri-agonist research peptide that activates the GLP-1, GIP, and glucagon receptors simultaneously. It is part of a new generation of incretin-receptor research compounds developed to study combined activation of multiple metabolic pathways. Quantum Labs supplies Retatrutide as a lyophilised powder for Australian research applications.
Retatrutide is studied alongside other incretin-receptor agonists — semaglutide (single-agonist GLP-1) and tirzepatide (dual-agonist GLP-1/GIP) — in pre-clinical and clinical research literature. The tri-agonist mechanism is the distinguishing feature that places it in its own research category. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
作用机制
文献关注其同时激动 GLP-1、GIP 与胰高血糖素受体。研究与受试人群的代谢率、饱腹感及能量消耗指标相关。
经 HPLC 验证，纯度规格 ≥99%。由获认可的第三方实验室独立检测。
Retatrutide — 常见问题
What is Retatrutide?
Retatrutide is a synthetic tri-agonist research peptide that simultaneously activates the GLP-1, GIP, and glucagon receptors. It is a newer-generation incretin-receptor research compound.
Is Retatrutide legal in Australia?
Retatrutide is not an approved therapeutic in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies Retatrutide for research use only — it is not a substitute for prescription weight-loss medication.
What is the difference between Retatrutide and Tirzepatide?
Tirzepatide is a dual-agonist activating GLP-1 and GIP receptors. Retatrutide is a tri-agonist activating GLP-1, GIP, and glucagon receptors. The added glucagon-receptor activity is the distinguishing pharmacological feature of Retatrutide.
What is the difference between Retatrutide and Mounjaro?
Mounjaro is the brand name for the approved prescription medicine tirzepatide. Retatrutide is a separate research peptide with an additional glucagon-receptor agonism. They are different molecules studied in parallel research literature. Quantum Labs does not supply prescription medicines.
What is the typical Retatrutide research dosage?
Published clinical research has used Retatrutide doses across a wide titration range. Research-protocol dosing varies by model. Human therapeutic dosing is not established. Quantum Labs supplies this compound for laboratory and pre-clinical research use only. It is not represented for human therapeutic use, and questions about clinical dosing, treatment effects, or personal use should be directed to a qualified medical practitioner.
与 Retatrutide 相关的指南
研究者还会浏览
10 瓶装立省 17%5-Amino-1MQ
冻干粉末50 mg · 3 strengths
NNMT 抑制剂研究化合物
10 瓶装立省 15%L-Carnitine
Sterile solution10 ml × 600 mg/ml
线粒体脂肪酸转运分子
收录于 1 套组合